CD8A and metastatic neoplasm: This analysis indicated that in fact only 10.1% CD8+ and 5.9% Tregs were intra-tumoral whereas 89.9% CD8+ and 94.1% Tregs were peri-tumoral in both primary and metastatic tumors (Fig. 4C).